Zobrazeno 1 - 6
of 6
pro vyhledávání: '"R E, Elmslie"'
Publikováno v:
The Journal of clinical investigation. 101(11)
In vivo transfection of established tumors with immunostimulatory genes can elicit antitumor immunity. Therefore, we evaluated the safety and efficacy of intratumoral injections of a bacterial superantigen with a cytokine gene in dogs with malignant
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ea0608eca181bd354de8b6e1f31ae57d
https://pubmed.ncbi.nlm.nih.gov/9616212
https://pubmed.ncbi.nlm.nih.gov/9616212
Autor:
G K, Ogilvie, A S, Moore, J E, Obradovich, R E, Elmslie, D M, Vail, R C, Straw, M D, Salmon, M K, Klein, S W, Atwater, P E, Ciekot
Publikováno v:
Journal of the American Veterinary Medical Association. 202(11)
Eighty-seven cats with histologically confirmed malignant tumors were used in a prospective study to determine the toxicity of mitoxantrone, a dihydroxyquinone derivative of anthracene, which was administered at 21-day intervals at dosages ranging fr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::2bafcd074e7594f07c6d4738763ec99a
https://pubmed.ncbi.nlm.nih.gov/8320152
https://pubmed.ncbi.nlm.nih.gov/8320152
Publikováno v:
American journal of veterinary research. 53(10)
Fifteen dogs were given doxorubicin, IV, at a dosage of 30 mg/m2 of body surface. A commercially available biological extract of Serratia marcescens (BESM) was administered SC to 9 of these dogs (0.04 mg/kg of body weight every third day, n = 2; 0.08
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d820b98e122fc9cd7adbc12951f972aa
https://pubmed.ncbi.nlm.nih.gov/1280926
https://pubmed.ncbi.nlm.nih.gov/1280926
Publikováno v:
Molecular biotherapy. 3(4)
Normal feline bone marrow-derived macrophages released maximum concentrations of interleukin-6, tumor necrosis factor, and interleukin-1 when stimulated with ImuVert (Cell Technology Inc, Boulder, CO, USA) at dosages of 1.0 microgram/ml, 5.0 microgra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::65bed7c6195876341af5657dde193794
https://pubmed.ncbi.nlm.nih.gov/1768375
https://pubmed.ncbi.nlm.nih.gov/1768375
Autor:
G K, Ogilvie, J E, Obradovich, R E, Elmslie, D M, Vail, A S, Moore, C R, Curtis, R C, Straw, K, Dickinson, M F, Cooper, S J, Withrow
Publikováno v:
Journal of the American Veterinary Medical Association. 198(9)
One hundred twenty-nine dogs with histologically confirmed malignant tumors were used in a prospective study to determine the toxicity of the new dihydroxyquinone derivative of anthracene, mitoxantrone, which was administered IV at 21-day intervals a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::502e8734334eed0144c25bfaac3ff72e
https://pubmed.ncbi.nlm.nih.gov/2061176
https://pubmed.ncbi.nlm.nih.gov/2061176
Autor:
G K, Ogilvie, J E, Obradovich, R E, Elmslie, D M, Vail, A S, Moore, R C, Straw, K, Dickinson, M F, Cooper, S J, Withrow
Publikováno v:
Journal of the American Veterinary Medical Association. 198(9)
One hundred twenty-six dogs with histologically confirmed, measurable malignant tumors were evaluated in a prospective study to determine the response to the antineoplastic drug mitoxantrone. Ninety-five dogs had been refractory to one or more treatm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::03787e6975db57a06665c59e55306ae9
https://pubmed.ncbi.nlm.nih.gov/2061177
https://pubmed.ncbi.nlm.nih.gov/2061177